Dr. Elizabeth Ko
Dr. Ko is originally from Seoul, South Korea. She completed her Bachelor of Science degree in Genetics at the University of Georgia followed by her Doctor of Pharmacy degree at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Ko completed her PGY-1 residency at the Oregon Health and Science University Hospital in Portland, OR. Dr. Ko’s major research project this year focuses on optimizing oral thyrosine kinase inhibitors doses in chronic myeloid Leukemia patients. Her professional interest include solid tumor, palliative care, and academia. Outside of residency, she enjoys oil painting, cooking, and visiting parks with her dog.
Dr. Gina Migneco
Dr. Migneco is originally from St. Louis, Missouri. She completed her Bachelor of Science degree in Biochemistry at Washington University in St. Louis followed by her Doctor of Pharmacy degree at the University of Maryland and her PGY-1 residency training at OHSU. Her professional interests include oncology and pediatrics. Dr. Migneco’s major research project this year focuses on evaluating the efficacy and safety of clofarabine/cytarabine remission reinduction in relapsed/refractory pediatric acute myeloid leukemia. Outside of residency, she enjoys going on hikes, biking, and discovering new restaurants in Portland.